Next-gen Alzheimer’s drugs extend independent living by months | WashU Medicine
medicine.washu.edu
New analysis recasts benefits of treatment in relation to day-to-day impacts on patients’ lives
  • AbouBenAdhem@lemmy.worldEnglish
    2·
    23 hours ago

    It looks like this study isn’t actually about the effect of the drugs, but about the best way of communicating expected treatment outcomes to patients.